✦ LIBER ✦

Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis

✍ Scribed by Adrian M. di Bisceglie; Zachary D. Goodman; Kamal G. Ishak; Jay H. Hoofnagle; Jacqueline J. Melpolder; Harvey J. Alter

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 784 KB
Volume: 14
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840140603

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of antibodies to n

Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up

✍ Eiji Tanaka; Kendo Kiyosawa; Yoshiyuki Nakatsuji; Yoshimichi Inoue; Tatsuo Miyam 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

To clarify the long-term clinical signficiance, antibody to hepatitis C virus (HCV) was examined using core (p22) and nonstructural (C100-3) protein assays in sera of 18 patients with non-A,non-B posttransfusion hepatitis (PTH-NANB) who were selected retrospectively. Each patient had been followed f

Long-term follow-up of anti-HBe-positive

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

✍ Giovanna Fattovich; Lucio Brollo; Alfredo Alberti; Patrizia Pontisso; Giuliano G 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Twenty-eight patients with chronic active hepatitis without cirrhosis who were positive for hepatitis B surface antigen and antibody to hepatitis B e antigen were followed for 1 to 15 years (mean 6.6 years) and underwent follow-up biopsy. At presentation, 12 of the 28 patients (43%) had hepatitis B

Long-term follow-up of alpha-interferon

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

✍ Monika van Zonneveld; Pieter Honkoop; Bettina E. Hansen; Hubertus G.M. Niesters; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Long-term follow-up of patients with chr

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

✍ Michiko Shindo; Adrian M. di Bisceglie; Jay H. Hoofnagle 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986

LONG-TERM FOLLOW-UP IN AIDS CLINICAL TRI

LONG-TERM FOLLOW-UP IN AIDS CLINICAL TRIALS

✍ DAVID A. SCHOENFELD 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

There are several different strategies for the follow-up of patients on AIDS clinical trials. In some trials, data are only collected until patients stop protocol therapy for any reason. Alternatively, patients are followed until they have disease progression or the study ends. It has been suggested

Long-term follow-up of antimitochondrial

Long-term follow-up of antimitochondrial antibody–positive autoimmune hepatitis

✍ Conor O'Brien; Supriya Joshi; Jordan J. Feld; Maha Guindi; Hans P. Dienes; E. Je 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 1 views

Antimitochondrial antibodies (AMAs) are the serological hallmark for primary biliary cirrhosis (PBC). When AMAs are detected in patients with chronic hepatitis, they negatively impact on the autoimmune hepatitis (AIH) scoring system. The purpose of this study was to determine if AMAs detected in the